University of Miami: Diabetes Research Institute

Miami, Florida 33136

1 studies enrolling now · 17 studies all time

What they study most

Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type I, Diabetes Type 2, Diabetes, Type 1, Diabetic Polyneuropathy, Hyperglycemia, Hypertension, New-onset Type 1 Diabetes Mellitus, Obesity, T1D

Studies at this site

• A Study of GNTI-122 in Adults Recently Diagnosed With T1D — Recruiting now
• Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec — Completed
• Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients — Stopped early
• Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression — Completed
• Tocilizumab (TCZ) in New-onset Type 1 Diabetes — Completed
• Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study) — Completed
• Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN) — Withdrawn before enrolling
• A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients — Completed
• Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder — NO_LONGER_AVAILABLE
• A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) — Completed
• A 2-Month Safety Follow-Up Trial — Completed
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks — Stopped early
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus — Completed
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy — Completed
• Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression — Completed
• Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen — Completed